TrialFrontiers in immunology2018

Polymorphisms in Toll-Like Receptor 10 and Tuberculosis Susceptibility: Evidence from Three Independent Series.

Yu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.